Scpharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 3.69, indicating more challenging environment then in the first quarter 2025, but still, it is a far cry from any concerns. Scpharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2025 quarter, has increased to 99 days, from 89 days, in the Mar 31 2025 quarter.

If we take a look into Healthcare sector 271 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1903, from overall ranking in the first quarter 2025 at 2357.

What is Receivable Turnover Ratio?
What is Scpharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SCPH Receivables Turnover Ratio	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Receivable Change	217.35 %	140.02 %	161.1 %	120.77 %	279.88 %
Y / Y Revenue Change	99.17 %	92.59 %	99.31 %	164.12 %	391.7 %
Receivable Turnover Ratio (TTM)	3.69	4.11	4.43	4.73	4.68
SCPH's Total Ranking	# 1903	# 2357	# 2706	# 2145	# 2589
Accounts Receivable average collection period days	99	89	82	77	78
Seq. Receivable Change	40.1 %	18.2 %	27.17 %	50.7 %	5.96 %
Seq. Revenue Change	36.5 %	-3.28 %	21.18 %	24.48 %	31.99 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 75
Healthcare Sector	# 272
Overall Market	# 1903

Receivable Turnover Ratio Statistics
High	Average	Low
0.49	0.32	0.12
(Jun 30 2025)		(Dec 31 2023)

SCPH Company Profile • Back to SCPH Efficiency Comparisons • Compare SCPH Receivables Turnover Ratio to its Competitors

Financial Statements
Scpharmaceuticals Inc 's Accounts Receivable	$ 19 Millions	Visit SCPH's Balance sheet
Scpharmaceuticals Inc 's Sales TTM	$ 50 Millions	Visit SCPH's Income Statement
Sources of SCPH's Revenues		Visit SCPH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SCPH's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SCPH's Growth Rates	SCPH's Roa	SCPH's Inventory Turnover Ratio	SCPH's Dividend Comparisons
SCPH's Profitability Ratios	SCPH's Roi	SCPH's Asset Turnover Ratio	SCPH's Dividend Growth
SCPH's Valuation Ratios	SCPH's Roe	SCPH's Financial Strength Ratios	SCPH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2025	Receivable at quarter ending Jun 30 2025
3m Company	7.04	$ 24,602.000 Millions	$ 3,495.750 Millions
Sight Sciences Inc	7.03	$ 75.149 Millions	$ 10.688 Millions
Ardelyx inc	7.02	$ 386.146 Millions	$ 54.980 Millions
Avita Medical Inc	7.02	$ 74.884 Millions	$ 10.671 Millions
Boston Scientific Corporation	7.00	$ 18,494.000 Millions	$ 2,641.750 Millions
Lemaitre Vascular Inc	6.99	$ 234.162 Millions	$ 33.495 Millions
Adm Tronics Unlimited Inc	6.99	$ 3.313 Millions	$ 0.474 Millions
Maravai Lifesciences Holdings Inc	6.98	$ 215.853 Millions	$ 30.942 Millions
Rigel Pharmaceuticals Inc	6.98	$ 267.921 Millions	$ 38.411 Millions
Iradimed Corporation	6.97	$ 77.635 Millions	$ 11.137 Millions
Maxcyte inc	6.97	$ 35.753 Millions	$ 5.130 Millions
Medpace Holdings Inc	6.95	$ 2,231.787 Millions	$ 321.012 Millions
Puma Biotechnology Inc	6.91	$ 238.062 Millions	$ 34.434 Millions
Vaso Corporation	6.89	$ 87.297 Millions	$ 12.672 Millions
Hca Healthcare Inc	6.89	$ 72,698.000 Millions	$ 10,553.250 Millions
Phibro Animal Health Corporation	6.86	$ 1,295.942 Millions	$ 188.933 Millions
Ceribell Inc	6.86	$ 76.234 Millions	$ 11.115 Millions
Angiodynamics Inc	6.86	$ 290.645 Millions	$ 42.383 Millions
Legend Biotech Corporation	6.85	$ 255.058 Millions	$ 37.257 Millions
Tela Bio Inc	6.84	$ 73.696 Millions	$ 10.778 Millions
Cerus Corporation	6.83	$ 190.983 Millions	$ 27.969 Millions
Nexalin Technology Inc	6.82	$ 0.175 Millions	$ 0.026 Millions
Solventum Corporation	6.82	$ 8,388.000 Millions	$ 1,230.500 Millions
Strata Skin Sciences Inc	6.80	$ 31.836 Millions	$ 4.681 Millions
Lakeland Industries Inc	6.80	$ 191.632 Millions	$ 28.183 Millions
Merit Medical Systems Inc	6.77	$ 1,433.025 Millions	$ 211.777 Millions
Edwards Lifesciences Corporation	6.76	$ 5,399.700 Millions	$ 798.350 Millions
Treace Medical Concepts Inc	6.76	$ 213.751 Millions	$ 31.606 Millions
Carlisle Companies Incorporated	6.76	$ 5,001.800 Millions	$ 740.000 Millions
Escalon Medical Corp	6.72	$ 12.046 Millions	$ 1.793 Millions

Date modified: 2026-08-29T17:39:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.